USING TECHNOLOGY TO DELIVER BETTER CHRONIC DISEASE MANAGEMENT Dr Eleanor Chew Dr Amit Vohra Clinical Lead Integrated Care Executive General Manager Sonic Clinical Services Sonic Clinical Services
‘Complex’ target group • High care needs • High risk of re-admissions • High level clinical care coordination ‘Multi - morbid’ target group • Complications of chronic disease • At risk of hospitalisation • Targeted care coordination ‘Uncomplicated’ target group • Controlled or low risk of complications • Low risk of hospitalisation • Supported self-care ‘At risk’ target group • Personalised patient education Smoking 13%
Stepped care approach Home care & individualised care High level care coordination Tailored interventions Care coordination Personalised CDM care plan Shared e-health record (cdmNet) Preventive Care Smart phone app (MediTracker) Patient education (GoShare) Patient Centred Medical Home
Technology supporting CDM • Risk stratification • Shared electronic medical records • Mobile app • Digitally enabled education
Patients over 45 years Risk Stratification NO Chronic Disease Diagnosis YES Smoker NO YES 1 Dx 2 Dx 3 Dx • Data extraction tool OR BP >160/100 OR • Risk factors/diagnoses Microalbuminuria NO YES Identification >20mcg/ml FGB >7.0mmol/L OR Patient OR eGFR <60 ml/min • Patient identification BMI > 40 OR OR BP >160/100 TC > 7.5mmol/L OR • Health assessment OR TC > 7.5mmol/L FHx Diabetes OR HbA1c >7.5 • Stratification Ineligible for WellNet • Selection Perform in clinic health assessment YES Assess HARP Chronic disease Stratification Selection & identified? <10 10 - 38 >38 NO FeelWell LiveWell StayWell BeWell
Shared electronic health records • Web based e-record shared & used by whole of care team including AHP • Digital care plans – guidelines based • Care coordination - assigns tasks & responsibilities to care team members • Tracking – team members contribute to care plan on completion of tasks
Patient mobile app
Digitally enabled education
WellNet Trial Locations Current Locations Size & Mix Target Cohort • 3 IPN & 3 non-IPN Practices. • 1050 Tier 2 and Tier 3 Patients. North Sydney Trial • LHD, PHN, BUPA, HCF, nib, Teachers & • 600 in evaluation cohort • Public & Private Patients DoH on Steering Committee. • Expanding to another 6 practices in • PHN confirmed expansion of trial to 2019 new practices in 2019-20 • 10-15 IPN & non-IPN Practices. • Target 400-600 Private Patients. AHSA Victoria Trial • AHSA, AU, GMHBA, Defence Health, People Care on Steering Committee. • 6-8 non-IPN practices • Target 800 Public patients SEMPHN Victoria Trial • Separate cohort of 40-50 Frequent Flyers • 5-6 IPN and non-IPN practices • Target 800-1000 patients Hunter PHN & nib Trial • Greater focus on obesity related chronic disease
Learnings – Risk stratification 5 chronic disease categories: Additional chronic diseases: • Cardiovascular • Osteoporosis • Respiratory • Low back pain • Diabetes • Cancers • Major joint disease • Kidney failure • Mental health • Liver disease
Learnings - cdmNet • Enables shared care planning and coordination • Can be confusing for GPs not familiar with it • Requires dedicated training • Sits outside other record systems
Learnings - MediTracker • Available to all WellNet patients • ‘Tech savvy’ more likely to download app • Check results and appointments • Access to medical record overseas • 60% continued to access app after completing WellNet program
Learnings - GoShare Not hitting the mark … • 35% viewed items • Older age cohort • Too much e-traffic • Contact too frequent • GPs not familiar with it
Evaluation findings - CMCRC Statistically significant improvement in: Self-reported Health Assessments Clinical Outcomes • HARP score • Systolic & diastolic BP • Patient Activation Measure (PAM) • Body Mass Index • Quality of Life score (EQ-5D-5L) • Waist circumference • Cardiovascular Disease Risk score • Hba1c • Psychological scores (K10 & DASS21) • Lipids inc TC, HDL, LDL, TG • Diabetes Risk Assessment (AusDRisk) • COPD Assessment Test (CAT)
CLINICIAN FEEDBACK “many silent or unattended to issues are uncovered and dealt with”.
PATIENT FEEDBACK
Thank you Questions?
Recommend
More recommend